SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 23,
2002
JOHNSON & JOHNSON
(Exact name of registrant as specified in its charter)
New Jersey 1-3215 22-1024240
(State or other Commission (I.R.S. Employer
jurisdiction File Number Identification No.)
of incorporation)
One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933
(Address of principal executive offices) (zip code)
Registrant's telephone number including area code: (732) 524-0400
Item 5. Other Events.
On October 18, 2002, Johnson & Johnson ("J&J") issued the
attached press release statement on the Amgen arbitration that is
filed as Exhibit 99.15 to this Form 8K. The unaudited
consolidated statements of earnings of J&J for the quarter and
nine month periods ended September 29, 2002 reflecting the
results of the Amgen arbitration is being filed as Exhibit 99.2O
to this Form 8K.
Item 7. Financial Statements, Pro Forma Financial Information and
Exhibits.
(c) Exhibits
Exhibit No. Description of Exhibit
99.15 Press Release dated October 18, 2002.
99.2O Unaudited consolidated statements of earnings
for the quarter and nine month periods ended
September 29, 2002
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
JOHNSON & JOHNSON
Date: October 23, 2002 By: /s/ Stephen J. Cosgrove
Stephen J. Cosgrove
Chief Accounting Officer